At this time, TRND is not accepting new investigator-initiated proposals to collaborate. However, interested investigators may contact TRND program staff at any time to discuss a potential collaboration. Please email TRND staff for further information.
Prospective collaborators are encouraged to connect with NCATS for timely notification when program updates are announced.
General Proposal Process
Proposals for collaborative research are assessed for scientific merit, program balance, availability of resources and technical feasibility. Steps include:
- Pre-screening with TRND staff to confirm eligibility. This “letter of intent” process consists of submission of a summary abstract of the proposed project and a telephone discussion with TRND staff.
- Eligible investigators submit a full proposal package. This package includes a formal written proposal and specified supporting documents.
- TRND staff assess proposals. Select proposals may receive additional input from staff in other NIH Institutes and Centers and from external drug development experts. Additional supporting data may be requested by TRND through a due diligence process.
As with any research or contract proposal submitted to NIH, proposals submitted to the TRND program are considered confidential and do not constitute public disclosure.